Skip to main content

Table 2 Comparison of the treatment between the control group and the intrathecal treatment group. Significant P values are noted with asterisks

From: The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE

 

Control group (n=192)

Intrathecal treatment group (n=194)

P value

Immunosuppressors during hospitalization, n (%)

 Cyclophosphamide

115(59.9)

136(70.1)

0.559

 Mycophenolate Mofetil

42(21.8)

34(17.5)

0.374

 Calcineurin inhibitors

10(5.21)

9(4.64)

0.819

 Other immunosuppressive agents

3(1.56)

4(2.06)

1

 Rituximab

1(0.52)

2(1.03)

1

 Combination of immunosuppressive agents

9(4.69)

6(3.10)

0.584

 None

12(6.25)

3(1.55)

0.018*

Time of hospitalization (days, median [IQR])

24[16.8,30]

31[20.36]

0.265

Time of follow-up (years, median [IQR])

2.51[1.08,3.80]

2.63[1.18, 4.48]

0.202